blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0351017

EP0351017 - Pharmaceutical composition useful for the treatment of cardiovascular diseases [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.11.1994
Database last updated on 25.09.2024
Most recent event   Tooltip19.11.1994No opposition filed within time limitpublished on 11.01.1995 [1995/02]
Applicant(s)For all designated states
ZAMBON GROUP S.p.A.
Via della Chimica, 9
36100 Vicenza / IT
[N/P]
Former [1992/40]For all designated states
ZAMBON GROUP S.p.A.
Via della Chimica, 9
I-36100 Vicenza / IT
Former [1990/03]For all designated states
SIMES, SOCIETA ITALIANA MEDICINALI E SINTETICI, S.P.A.
Via della Chimica 9
I-36100 Vicenza / IT
Inventor(s)01 / Casagrande, Cesare
Via Campogallo, 21/67
I-20020 Arese (Milano) / IT
02 / Licciardello, Luciano
Via Borgazzi, 38
I-20052 Monza (Milano) / IT
[1990/03]
Representative(s)Marchi, Massimo, et al
Marchi & Partners S.r.l.
Via Vittor Pisani, 13
20124 Milano / IT
[N/P]
Former [1990/03]Marchi, Massimo, et al
c/o Marchi & Mittler s.r.l. Viale Lombardia 20
I-20131 Milano / IT
Application number, filing date89201830.011.07.1989
[1990/03]
Priority number, dateIT1988002136915.07.1988         Original published format: IT 2136988
[1990/03]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0351017
Date:17.01.1990
Language:EN
[1990/03]
Type: A3 Search report 
No.:EP0351017
Date:30.05.1990
Language:EN
[1990/22]
Type: B1 Patent specification 
No.:EP0351017
Date:19.01.1994
Language:EN
[1994/03]
Search report(s)(Supplementary) European search report - dispatched on:EP10.04.1990
ClassificationIPC:A61K45/06, A61K31/22, A61K31/40, A61K31/55, A61K31/675, A61K31/495, A61K31/535, A61K31/395, A61K37/02, // (A61K31/40, 31:22),(A61K31/55, 31:22),(A61K31/675, 31:22),(A61K31/495, 31:22),(A61K31/535, 31:22),(A61K31/395, 31:22),(A61K37/02, 31:22),(A61K45/06, 31:22), A61K31:22, A61K31:195
[1990/03]
CPC:
A61K31/22 (EP,US); A61K31/395 (EP,US); A61K38/556 (EP,US);
A61K45/06 (EP,US); A61P43/00 (EP); A61P9/00 (EP);
A61P9/12 (EP) (-)
C-Set:
A61K31/22, A61K2300/00 (EP,US);
A61K31/22, A61K31/195 (US,EP);
A61K31/395, A61K31/22 (EP,US);
A61K31/40, A61K31/22 (US,EP);
A61K31/495, A61K31/22 (EP,US);
A61K31/535, A61K31/22 (EP,US);
A61K31/55, A61K31/22 (US,EP);
A61K31/675, A61K31/22 (EP,US);
A61K38/00, A61K31/22 (US,EP);
A61K38/556, A61K2300/00 (US,EP)
(-)
Designated contracting statesAT,   BE,   CH,   DE,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1990/03]
TitleGerman:Pharmazeutische Zusammensetzung, verwendbar bei der Behandlung von Herzgefässerkrankungen[1990/03]
English:Pharmaceutical composition useful for the treatment of cardiovascular diseases[1990/03]
French:Composition pharmaceutique utile dans le traitement des maladies cardiovasculaires[1990/03]
Examination procedure17.09.1990Examination requested  [1990/48]
05.12.1991Despatch of a communication from the examining division (Time limit: M04)
17.03.1992Reply to a communication from the examining division
03.11.1992Despatch of a communication from the examining division (Time limit: M02)
30.12.1992Reply to a communication from the examining division
19.05.1993Despatch of communication of intention to grant (Approval: Yes)
08.07.1993Communication of intention to grant the patent
24.09.1993Fee for grant paid
24.09.1993Fee for publishing/printing paid
Opposition(s)20.10.1994No opposition filed within time limit [1995/02]
Fees paidRenewal fee
28.06.1991Renewal fee patent year 03
01.07.1992Renewal fee patent year 04
19.07.1993Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]  - CARDIOVASCULAR DRUGS AND THERAPY, vol. 2, 1988, pages 83-91, Kluwer, US; I. CANTELLI, D. BRACCHETTI: "Combinaton of positive inotropic and vasodilating substances in congestive heart failure"
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.